"High percentage of the retailer who think they can out-smart the stock market and enter lose making penny stock and dream to become a millionaire, majority will lose big amount of money compare to the retailer who put money on profit making company that its share price Rm1 and above counter"
Want to go vaccine counter? go to genuine vaccine counter example Pharmaniaga and Duopharma. Malaysia gave licence only to Pharmaniaga and Duopharma to distribute covid19. Dont act smart and think Bintai,Titijaya,Kanger,Inix can sell vaccine it will never happen in Million years in Malaysia. Never touch any lose making penny stock counter who try to ride on vaccine theme.
Want to invest on glove counter? invest only on genuine glove counter like
Top glove, Supermax, Hartalega, Kossan, Ruberex, Comfort, Careplus, Hlt and LKL.
Mostly Sinopharm will get ready the vaccine in single dose bottle packaging, not in bulky volume, concern on the security and quality control at the initial stage, so not 100,% will need service from pharmaniaga and duopharma...
Since Sinopharm already sign the agreement for to collaborate with Titijaya, very high opportunity to continue vaccine business with Titijaya, or otherwise have to find another company to start over the new cooporation, this surely will hurt the relationship with Titijaya, besides, it also require long procedure, energy, cost and time consuming to study another company that can be trusted to cooperated with at such critical time, why not just award the business to Titijaya and strengthen the partnership between both of them. That's why logical thinking, Titijaya shall be awarded for the vaccine business with Sinopharm....just my personal opinion, relax..
At least Titijaya should give some enlightenment regarding their cooperation. For example 'Their cooperation with Sinopharm regarding the potential of Titijaya as their vaccine distributor in Malaysia as per the MOU is still ongoing'
10. ESTIMATED TIMEFRAME FOR COMPLETION Barring any unforeseen circumstances and subject to all required approval being obtained, the Proposed Diversification is expected to be completed by November 2020. For shareholders' information purpose, the Proposed Diversification shall take immediate effect upon obtaining the approval of Titijaya's shareholders at the EGM.
That’s why I always say fake ones will announce fake news to goreng stock
Real ones are busy preparing the necessary and that’s why we don’t see Titijaya rushing to make any premature announcement to goreng its stock price. Real ones focus how to make things possible behind the scene.
Please read the agreement again and it’s clearly stated that Titijaya has exclusive right to distribute Sinopharm medical products (vaccine is a type of medical product) to 5 countries, Indonesia, Thailand, Singapore, Australia and Malaysia, with around 400 million population.
The agreement also states that the Special Built Medical Base will be built with the assistance and expertise of Sinopharm.
We are entering Oct soon and based on previous communication, EGM will be held soon and more details will be announced by November 2020!
More importantly, vaccines from Sinopharm are Inactivated or Attenuated Coronavirus type hence the vaccines can be easily distributed as Sinopharm Vaccines DON’T need ultra low temperature storage/distribution system.
why does sinopaharm require 2 distributors in mlysai for their covid 19 vaccine. Sinopharm has already sign mou with solutions so why suddenly now sign up with ttijaya?? will there be a third or mayb a 4th distributor in mlysia???
Yes, friendship, as mentioned before, so far Sinopharm only collaborate and sign agreement with Titijaya, yes vaccine shall be categorized as medical products, Titijaya potential to limit up anytime.
Dr LimKH, you can dream on your Pharma and DPharma coz when Titijaya brings in Sinopharm vaccine, they don’t need Pharma and Dpharma to do fill and bottling at all haha
For Titijaya, very soon everyone will know that the details about its partnership Titijaya has with Sinopharm when they do the announcements in October.
More importantly, the article didn’t mention anything about Titijaya being a goreng stock, coz Titijaya is the only real beneficiary of vaccine play!
Even WHO about to give approval to Sinopharm vaccine soon
Once Malaysia government endorse vaccine from Sinopharm, Titijaya will be able to provide more information regarding their partnership with Sinopharm soon
Friendship, very fantastic sharing, yes, sinopharm's vaccine from China is mostly ready to use and no need to do fill and bottling as security and quality constraints
Sinopharm has indicated that their vaccines will need 2 doses.
Titijaya has a distribution market of 400 million population, so that’s 800 million! Please calculate yourself how much profit Titijaya can make from this.
That’s why Titijaya is the biggest and most underpriced Vaccine Gem in the market.
Sinopharm Chairman Liu Jingzhen told China's state media Guangming Daily that the company's inactivated COVID-19 vaccines would cost less than 1,000 yuan ($145) for two doses.
Only Tanah Melayu alone population 32m
32,000,000 x Rm 400 per dose = Rm 12 , 800 , 000 , 000 . 00 Wakakakaka
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
salman
1,582 posts
Posted by salman > 2020-09-23 10:22 | Report Abuse
Newbie0001 Kanger price is dropping now...what news?